| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.357 | 0.005 | 0.435 | Antibacterial (Helicobacter pylori) | 0.435 0.004 DBMET03402 0.18 0.028 DBMET03403 | DBMET03402 | |
| 0.429 | 0.094 | 0.429 | Caspase 9 stimulant | 0.333 0.16 DBMET03403 | ||
| 0.402 | 0.076 | 0.402 | Antibacterial | 0.362 0.095 DBMET03402 0.224 0.202 DBMET03403 | ||
| 0.367 | 0.078 | 0.367 | Calpain 2 inhibitor | |||
| 0.33 | 0.043 | 0.363 | Hypoglycemic | 0.361 0.035 DBMET03402 0.363 0.035 DBMET03403 | DBMET03403 | |
| 0.279 | 0.057 | 0.279 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.23 | 0.028 | 0.23 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.222 | 0.026 | 0.476 | Insulin secretagoues | 0.188 0.043 DBMET03402 0.476 0.005 DBMET03403 | DBMET03403 | |
| 0.309 | 0.119 | 0.402 | Histamine release inhibitor | 0.402 0.074 DBMET03402 | DBMET03402 | |
| 0.209 | 0.024 | 0.452 | Alkylator | 0.452 0.006 DBMET03402 0.168 0.038 DBMET03403 | DBMET03402 | |
| 0.205 | 0.028 | 0.205 | Cell wall synthesis inhibitor | 0.185 0.037 DBMET03402 | ||
| 0.171 | 0.007 | 0.217 | Lanosterol 14 alpha demethylase inhibitor | 0.124 0.027 DBMET03402 0.217 0.004 DBMET03403 | DBMET03403 | |
| 0.269 | 0.111 | 0.35 | Thyroid hormone antagonist | 0.35 0.073 DBMET03403 | DBMET03403 | |
| 0.24 | 0.085 | 0.24 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.241 | 0.089 | 0.383 | Cardiotonic | 0.383 0.032 DBMET03402 0.356 0.038 DBMET03403 | DBMET03402 | |
| 0.218 | 0.097 | 0.218 | DNA synthesis inhibitor | 0.176 0.16 DBMET03402 0.18 0.154 DBMET03403 | ||
| 0.162 | 0.046 | 0.539 | Cyclooxygenase 2 inhibitor | 0.259 0.019 DBMET03402 0.539 0.004 DBMET03403 | DBMET03403 | |
| 0.216 | 0.103 | 0.492 | DNA damaging | 0.492 0.014 DBMET03402 | DBMET03402 | |
| 0.147 | 0.036 | 0.227 | Interleukin 8 antagonist | 0.227 0.008 DBMET03402 0.138 0.042 DBMET03403 | DBMET03402 | |
| 0.169 | 0.057 | 0.578 | Cyclooxygenase inhibitor | 0.274 0.022 DBMET03402 0.578 0.004 DBMET03403 | DBMET03403 | |
| 0.235 | 0.128 | 0.308 | Thyroid hormone beta antagonist | 0.308 0.084 DBMET03403 | DBMET03403 | |
| 0.144 | 0.062 | 0.144 | Heat shock protein 70 antagonist | |||
| 0.124 | 0.042 | 0.124 | Urease inhibitor | |||
| 0.104 | 0.026 | 0.104 | Peroxisome proliferator-activated receptor gamma agonist | 0.062 0.056 DBMET03403 | ||
| 0.099 | 0.03 | 0.116 | Thioredoxin reductase inhibitor | 0.116 0.019 DBMET03402 0.102 0.027 DBMET03403 | DBMET03402 | |
| 0.136 | 0.066 | 0.136 | Tubulin antagonist | |||
| 0.135 | 0.066 | 0.444 | Cyclooxygenase 1 inhibitor | 0.159 0.052 DBMET03402 0.444 0.005 DBMET03403 | DBMET03403 | |
| 0.12 | 0.071 | 0.12 | Aldehyde dehydrogenase inhibitor | 0.113 0.078 DBMET03402 | ||
| 0.072 | 0.023 | 0.072 | Bombesin 3 receptor antagonist | 0.067 0.026 DBMET03402 0.067 0.026 DBMET03403 | ||
| 0.163 | 0.119 | 0.163 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.046 | 0.006 | 0.046 | Thiazolidinedione | 0.04 0.008 DBMET03402 0.04 0.008 DBMET03403 | ||
| 0.057 | 0.023 | 0.057 | Alpha 1b adrenoreceptor agonist | |||
| 0.136 | 0.103 | 0.136 | CF transmembrane conductance regulator agonist | |||
| 0.084 | 0.06 | 0.084 | Epidermal growth factor antagonist | 0.077 0.07 DBMET03402 | ||
| 0.243 | 0.221 | 0.415 | Cyclophilin D inhibitor | 0.271 0.19 DBMET03402 0.415 0.083 DBMET03403 | DBMET03403 | |
| 0.225 | 0.205 | 0.225 | Transcription factor inhibitor | |||
| 0.119 | 0.102 | 0.119 | Cytidine deaminase inhibitor | |||
| 0.133 | 0.118 | 0.548 | Interleukin 6 antagonist | 0.548 0.004 DBMET03402 0.147 0.094 DBMET03403 | DBMET03402 | |
| 0.024 | 0.011 | 0.074 | Hexokinase stimulant | 0.028 0.009 DBMET03402 0.074 0.004 DBMET03403 | DBMET03403 | |
| 0.099 | 0.086 | 0.099 | Nav1.5 sodium channel blocker | |||
| 0.046 | 0.034 | 0.046 | Benzodiazepine inverse agonist | |||
| 0.072 | 0.06 | 0.132 | Focal adhesion kinase 1 inhibitor | 0.132 0.014 DBMET03403 | DBMET03403 | |
| 0.07 | 0.059 | 0.071 | ErbB-2 antagonist | 0.071 0.058 DBMET03403 | DBMET03403 | |
| 0.209 | 0.2 | 0.379 | Calcium channel activator | 0.379 0.033 DBMET03402 | DBMET03402 | |
| 0.054 | 0.047 | 0.121 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.121 0.012 DBMET03403 | DBMET03403 | |
| 0.09 | 0.086 | 0.09 | DNA intercalator | |||
| 0.083 | 0.082 | 0.083 | Sphingomyelinase inhibitor | |||
| 0.059 | 0.059 | 0.072 | Transcription factor RelA inhibitor | 0.072 0.027 DBMET03402 0.063 0.046 DBMET03403 | DBMET03402 | |
| 0.017 | 0.026 | 0.027 | Alpha 1a adrenoreceptor agonist | 0.022 0.017 DBMET03402 0.027 0.012 DBMET03403 | DBMET03403 | |
| 0.054 | 0.063 | 0.062 | Carbonic anhydrase V inhibitor | 0.062 0.051 DBMET03403 | DBMET03403 | |
| 0.053 | 0.063 | 0.086 | Nitric oxide donor | 0.079 0.023 DBMET03402 0.086 0.017 DBMET03403 | DBMET03403 | |
| 0.01 | 0.022 | 0.013 | 5 Lipoxygenase activating protein inhibitor | 0.013 0.011 DBMET03403 | DBMET03403 | |
| 0.024 | 0.041 | 0.076 | Glucose-dependent insulinotropic receptor agonist | 0.061 0.007 DBMET03402 0.076 0.005 DBMET03403 | DBMET03403 | |
| 0.167 | 0.184 | 0.198 | Prostaglandin dehydrogenase inhibitor | 0.198 0.157 DBMET03402 | DBMET03402 | |
| 0.102 | 0.121 | 0.679 | Interleukin 1 antagonist | 0.679 0.004 DBMET03402 | DBMET03402 | |
| 0.068 | 0.088 | 0.093 | Falcipain 2 inhibitor | 0.093 0.057 DBMET03403 | DBMET03403 | |
| 0.069 | 0.092 | 0.094 | Falcipain inhibitor | 0.094 0.059 DBMET03403 | DBMET03403 | |
| 0.087 | 0.119 | 0.357 | MAP kinase 12 inhibitor | 0.357 0.005 DBMET03402 | DBMET03402 | |
| 0.126 | 0.16 | 0.237 | Non-steroidal antiinflammatory agent | 0.208 0.065 DBMET03402 0.237 0.048 DBMET03403 | DBMET03403 | |
| 0.02 | 0.057 | 0.087 | G protein-coupled receptor agonist | 0.065 0.011 DBMET03402 0.087 0.007 DBMET03403 | DBMET03403 | |
| 0.157 | 0.194 | 0.197 | Lipoxygenase inhibitor | 0.197 0.143 DBMET03402 | DBMET03402 | |
| 0.162 | 0.208 | 0.21 | Thioredoxin glutathione reductase inhibitor | 0.21 0.164 DBMET03403 | DBMET03403 | |
| 0.006 | 0.071 | 0.012 | Glucose-dependent insulinotropic receptor antagonist | 0.012 0.008 DBMET03403 | DBMET03403 | |
| 0.077 | 0.151 | 0.131 | Cytokine production inhibitor | 0.131 0.079 DBMET03402 | DBMET03402 | |
| 0.078 | 0.16 | 0.178 | Toll-Like receptor 9 antagonist | 0.158 0.058 DBMET03402 0.178 0.046 DBMET03403 | DBMET03403 | |
| 0.14 | 0.225 | 0.285 | Peptidyltransferase inhibitor | 0.285 0.031 DBMET03402 0.235 0.062 DBMET03403 | DBMET03402 | |
| 0.048 | 0.156 | 0.09 | 5-Lipoxygenase inhibitor | 0.09 0.071 DBMET03402 | DBMET03402 | |
| 0.013 | 0.136 | 0.04 | Dihydropteroate synthase inhibitor | 0.04 0.027 DBMET03403 | DBMET03403 | |
| 0.013 | 0.138 | 0.042 | Glycine transporter inhibitor | 0.042 0.039 DBMET03403 | DBMET03403 | |
| 0.093 | 0.219 | 0.176 | Tumour necrosis factor antagonist | 0.176 0.071 DBMET03402 | DBMET03402 | |
| 0.041 | 0.179 | 0.067 | Exportin-1 inhibitor | 0.067 0.051 DBMET03402 | DBMET03402 | |
| 0.14 | 0.287 | 0.252 | Tyrosine 3 hydroxylase inhibitor | 0.252 0.066 DBMET03403 | DBMET03403 | |
| 0.074 | 0.223 | 0.118 | Sphingosine 1-phosphate receptor 4 antagonist | 0.118 0.075 DBMET03403 | DBMET03403 | |
| 0.053 | 0.219 | 0.444 | Interleukin 1b antagonist | 0.444 0.005 DBMET03402 | DBMET03402 | |
| 0.111 | 0.279 | 0.412 | 5 Hydroxytryptamine release stimulant | 0.412 0.043 DBMET03402 0.262 0.083 DBMET03403 | DBMET03402 | |
| 0.078 | 0.248 | 0.54 | Interleukin antagonist | 0.54 0.017 DBMET03402 | DBMET03402 | |
| 0.047 | 0.219 | 0.318 | MAP kinase 13 inhibitor | 0.318 0.005 DBMET03402 | DBMET03402 | |
| 0.005 | 0.18 | 0.03 | Glycine transporter 1 inhibitor | 0.03 0.028 DBMET03403 | DBMET03403 | |
| 0.11 | 0.328 | 0.245 | Immunomodulator | 0.245 0.119 DBMET03402 | DBMET03402 | |
| 0.079 | 0.298 | 0.251 | Vasodilator | 0.251 0.068 DBMET03402 | DBMET03402 | |
| 0.071 | 0.329 | 0.153 | Pregnane X receptor agonist | 0.153 0.048 DBMET03403 | DBMET03403 | |
| 0.011 | 0.27 | 0.055 | Phosphodiesterase 4C inhibitor | 0.055 0.04 DBMET03403 | DBMET03403 | |
| 0.008 | 0.28 | 0.05 | Liver X receptor alpha antagonist | 0.05 0.005 DBMET03403 | DBMET03403 | |
| 0.008 | 0.29 | 0.073 | Liver X receptor antagonist | 0.073 0.006 DBMET03403 | DBMET03403 | |
| 0.015 | 0.306 | 0.059 | Bromodomain-containing protein 4 inhibitor | 0.059 0.033 DBMET03403 | DBMET03403 | |
| 0.015 | 0.31 | 0.19 | MAP kinase 11 inhibitor | 0.19 0.01 DBMET03402 | DBMET03402 | |
| 0.004 | 0.336 | 0.016 | Sodium/hydrogen exchanger inhibitor | 0.016 0.014 DBMET03403 | DBMET03403 | |
| 0.011 | 0.349 | 0.079 | Histone deacetylase SIRT2 inhibitor | 0.079 0.046 DBMET03402 | DBMET03402 | |
| 0.02 | 0.5 | 0.067 | DNA helicase inhibitor | 0.067 0.02 DBMET03403 | DBMET03403 | |
| 0.009 | 0.512 | 0.102 | H+/K+-transporting ATPase inhibitor | 0.102 0.009 DBMET03402 | DBMET03402 | |
| 0.08 | 0.585 | 0.376 | Antiinflammatory | 0.376 0.154 DBMET03402 0.352 0.171 DBMET03403 | DBMET03402 | |
| 0.005 | 0.591 | 0.081 | Liver X receptor agonist | 0.081 0.01 DBMET03403 | DBMET03403 | |
| 0.011 | 0.621 | 0.044 | Cathepsin F inhibitor | 0.044 0.022 DBMET03403 | DBMET03403 | |
| 0.014 | 0.633 | 0.115 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.115 0.086 DBMET03402 | DBMET03402 | |
| 0.038 | 0.737 | 0.206 | MAP-kinase-activated kinase 5 inhibitor | 0.206 0.096 DBMET03402 | DBMET03402 | |
| 0.011 | 0.743 | 0.079 | Viral attachment inhibitor | 0.079 0.052 DBMET03402 | DBMET03402 | |
| 0.015 | 0.774 | 0.384 | EphB2 antagonist | 0.384 0.019 DBMET03402 | DBMET03402 | |
| 0.033 | 0.815 | 0.363 | Death-associated protein kinase 2 inhibitor | 0.363 0.004 DBMET03402 | DBMET03402 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |